Exploiting the HIV-chemokine nexus.
Cohen
J
J
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000276:immunology / Q000628:therapy* / Q000821:virology; D000818:Animals; D030801:Animals, Genetically Modified; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal; D018925:Chemokines / Q000378:metabolism / Q000627:therapeutic use*; D004195:Disease Models, Animal; D015195:Drug Design; D006678:HIV / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D019713:Receptors, CCR5; D018121:Receptors, Cytokine / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D015728:Receptors, HIV / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D000911:Antibodies, Monoclonal; D018925:Chemokines; D019713:Receptors, CCR5; D018121:Receptors, Cytokine; D015728:Receptors, HIV